Geadah D - Search Results

1

Myoglobin clearance and removal during continuous venovenous hemofiltration.

Amyot SL, Leblanc M, Thibeault Y, Geadah D, Cardinal J. Amyot SL, et al. Among authors: geadah d. Intensive Care Med. 1999 Oct;25(10):1169-72. doi: 10.1007/s001340051031. Intensive Care Med. 1999. PMID: 10551978

2

Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters.

Troyanov S, Cardinal J, Geadah D, Parent D, Courteau S, Caron S, Leblanc M. Troyanov S, et al. Among authors: geadah d. Nephrol Dial Transplant. 2003 May;18(5):961-6. doi: 10.1093/ndt/gfg055. Nephrol Dial Transplant. 2003. PMID: 12686672

3

Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy.

Troyanov S, Geadah D, Ghannoum M, Cardinal J, Leblanc M. Troyanov S, et al. Among authors: geadah d. Intensive Care Med. 2004 Aug;30(8):1662-5. doi: 10.1007/s00134-004-2333-2. Epub 2004 May 20. Intensive Care Med. 2004. PMID: 15156308

4

High dialysate flow rate continuous arteriovenous hemodialysis: a new approach for the treatment of acute renal failure and tumor lysis syndrome.

Pichette V, Leblanc M, Bonnardeaux A, Ouimet D, Geadah D, Cardinal J. Pichette V, et al. Among authors: geadah d. Am J Kidney Dis. 1994 Apr;23(4):591-6. doi: 10.1016/s0272-6386(12)80384-2. Am J Kidney Dis. 1994. PMID: 8154498

5

Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis.

Bonnardeaux A, Pichette V, Ouimet D, Geadah D, Habel F, Cardinal J. Bonnardeaux A, et al. Among authors: geadah d. Am J Kidney Dis. 1992 Jan;19(1):31-8. doi: 10.1016/s0272-6386(12)70199-3. Am J Kidney Dis. 1992. PMID: 1739079

6

N-acetylprocainamide intoxication with torsade de pointes treated by high dialysate flow rate continuous arteriovenous hemodiafiltration.

Leblanc M, Pichette V, Madore F, Ouimet D, Geadah D, Cardinal J. Leblanc M, et al. Among authors: geadah d. Crit Care Med. 1995 Mar;23(3):589-93. doi: 10.1097/00003246-199503000-00027. Crit Care Med. 1995. PMID: 7533068 No abstract available.

7

Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit.

Pichette V, Geadah D, du Souich P. Pichette V, et al. Among authors: geadah d. Drug Metab Dispos. 1999 Jan;27(1):81-5. Drug Metab Dispos. 1999. PMID: 9884313

8

Folic acid and pyridoxal-5'-phosphate losses during high-efficiency hemodialysis in patients without hydrosoluble vitamin supplementation.

Leblanc M, Pichette V, Geadah D, Ouimet D. Leblanc M, et al. Among authors: geadah d. J Ren Nutr. 2000 Oct;10(4):196-201. doi: 10.1053/jren.2000.16327. J Ren Nutr. 2000. PMID: 11070147

9

Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates.

Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J. Brunet S, et al. Among authors: geadah d. Am J Kidney Dis. 1999 Sep;34(3):486-92. doi: 10.1016/s0272-6386(99)70076-4. Am J Kidney Dis. 1999. PMID: 10469859

10

Serum concentrations and clearances of folic acid and pyridoxal-5-phosphate during venovenous continuous renal replacement therapy.

Fortin MC, Amyot SL, Geadah D, Leblanc M. Fortin MC, et al. Among authors: geadah d. Intensive Care Med. 1999 Jun;25(6):594-8. doi: 10.1007/s001340050908. Intensive Care Med. 1999. PMID: 10416911 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results